Aligos Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops therapeutics to address unmet medical needs in viral and liver diseases. Aligos uses its oligonucleotide and small molecule platforms to develop pharmacologically optimized drug candidates for use in combination regimens. Its lead drug candidates are ALG-010133, ALG-000184, ALG-020572, ALG-055009, as well as siRNA -based candidates, ALG-125755, ALG-125097, ALG-125819. Aligos was incorporated in 2018 and is headquartered in South San Francisco, CA.
What is Aligos Therapeutics's quote symbol?
What is the 52 week high and low for Aligos Therapeutics (NASDAQ: ALGS)?
How much is Aligos Therapeutics stock worth today?
How much is Aligos Therapeutics's stock price per share?
What is Aligos Therapeutics's Market Cap?